Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Jackisch

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Breast Care (Basel, Switzerland)|August 9, 2017
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017Cornelia Liedtke, Marc Thill, Christian Jackisch, et al.
Human Immunology|September 29, 2009
Suppressive activity rather than frequency of FoxP3(+) regulatory T cells is essential for CA-125-specific T-cell activation after abagovomab treatmentSilke Reinartz, Jacobus Pfisterer, Andreas du Bois, et al.
Deutsches Arzteblatt International|September 18, 2015
The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-upElke Peters, Tobias Anzeneder, Christian Jackisch, et al.
Archives of Gynecology and Obstetrics|May 13, 2008
Restrictive dermopathy: a rare laminopathyMarc Thill, Thuy Duong Nguyen, Manfred Wehnert, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2005
Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptorAchim Rody, Raihanatou Diallo, Christopher Poremba, et al.
Breast (Edinburgh, Scotland)|April 2, 2021
Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping reviewHans-Christian Kolberg, Christian Jackisch, Sara A Hurvitz, et al.
Future Oncology (London, England)|August 29, 2014
Neoadjuvant breast cancer treatment as a sensitive setting for trastuzumab biosimilar development and extrapolationChristian Jackisch, Frank A Scappaticci, Dominik Heinzmann, et al.
Breast Care (Basel, Switzerland)|April 21, 2025
A Decade of AGO QS-Mamma: Adherence to the Recommendations of the AGO Breast Committee for Diagnosis and Treatment in EBC in Routine Therapy in GermanyChristian Jackisch, Wolfgang Janni, Volkmar Müller, et al.
British Journal of Haematology|December 6, 2008
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia StudyRuth Pettengell, André Bosly, Thomas D Szucs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2010
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia StudyMatthias Schwenkglenks, Ruth Pettengell, Christian Jackisch, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Breast Care (Basel, Switzerland)|August 9, 2017
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2017Cornelia Liedtke, Marc Thill, Christian Jackisch, et al.
Human Immunology|September 29, 2009
Suppressive activity rather than frequency of FoxP3(+) regulatory T cells is essential for CA-125-specific T-cell activation after abagovomab treatmentSilke Reinartz, Jacobus Pfisterer, Andreas du Bois, et al.
Deutsches Arzteblatt International|September 18, 2015
The Treatment of Primary Breast Cancer in Older Women With Adjuvant Therapy: A Retrospective Analysis of Data From Over 3000 Patients From the PATH Biobank, With Two-Year Follow-upElke Peters, Tobias Anzeneder, Christian Jackisch, et al.
Archives of Gynecology and Obstetrics|May 13, 2008
Restrictive dermopathy: a rare laminopathyMarc Thill, Thuy Duong Nguyen, Manfred Wehnert, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|February 22, 2005
Androgen receptor expression in ductal carcinoma in situ of the breast: not a helpful marker for classification such as estrogen receptor alpha and progesterone receptorAchim Rody, Raihanatou Diallo, Christopher Poremba, et al.
Breast (Edinburgh, Scotland)|April 2, 2021
Is weight-based IV dosing of trastuzumab preferable to SC fixed-dose in some patients? A systematic scoping reviewHans-Christian Kolberg, Christian Jackisch, Sara A Hurvitz, et al.
Future Oncology (London, England)|August 29, 2014
Neoadjuvant breast cancer treatment as a sensitive setting for trastuzumab biosimilar development and extrapolationChristian Jackisch, Frank A Scappaticci, Dominik Heinzmann, et al.
Breast Care (Basel, Switzerland)|April 21, 2025
A Decade of AGO QS-Mamma: Adherence to the Recommendations of the AGO Breast Committee for Diagnosis and Treatment in EBC in Routine Therapy in GermanyChristian Jackisch, Wolfgang Janni, Volkmar Müller, et al.
British Journal of Haematology|December 6, 2008
Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia StudyRuth Pettengell, André Bosly, Thomas D Szucs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2010
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia StudyMatthias Schwenkglenks, Ruth Pettengell, Christian Jackisch, et al.
Pageof 24